Captor Therapeutics Spolka Akcyjna

zł 54.00As of Sun 8 Nov 2026, 12:00 UTC
WSE:CTXHealthcare
Country Poland
PE (Fwd) •••
TSR 6Y CAGR (19.42%)
Div yield —
ROE (80.62%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM 11.80%
Mkt cap zł 343.1M
ROIC (50.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 52
(4.60%)
179.55%
Hold 5|1|9|10|1
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.51
0.56
0.56
0.54
0.54%
10.90%
7.05%
6.96%
Revenuezł M
26.32
26.27
26.80
26.18
11.06%
4.96%
6.29%
5.44%
Peers (US$86.64M)
Cap (US$)
PE
96.40M
—
75.03M
—
Capital
TTM
5Y
10Y
Leveragex
1.794
(0.148)
(0.137)
EBIT/Intx
0.849
0.269
0.267
Own earn%
88.56
85.67
81.14
Sh yield%
28.71
51.73
49.03
Owners
Insiders/Inst%
5.43
27.14
Short interest%
3.16
SBC / revenue%
4.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–5
$1 testx
2.8
Incr. ROIC%
9